A new healthcare initiative is being developed in your region with the intention of reducing cancer deaths. As a hepatologist, you are approached for advice on how liver cancer deaths can be prevented. The staff of the healthcare initiative would like to understand how current evidence can support the best use of their resources.

What approach to diagnosis of hepatocellular carcinoma do you recommend for your region?